Gene · 23600
Papers2,301
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,301
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical Characteristics of Molecularly Defined Renal Cell Carcinomas. | Curr Issues Mol Biol | 2023 | 37367052 | PubTator, text mining | PubMed |
| Proteome Landscapes of Human Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. | Mol Cell Proteomics | 2023 | 37353004 | PubTator, text mining | PubMed |
| Characterization and evaluation of gene fusions as a measure of genetic instability and disease prognosis in prostate cancer. | BMC Cancer | 2023 | 37349736 | PubTator, text mining | PubMed |
| Case Report: The ultrasound features of acquired cystic disease-associated renal cell carcinoma: a case series. | Front Oncol | 2023 | 37333808 | PubTator, text mining | PubMed |
| Basal Cell Carcinoma of the Prostate Misdiagnosed as High-Grade Urothelial Cancer - A Case Report of a Diagnostic Pitfall. | Res Rep Urol | 2023 | 37324807 | PubTator, text mining | PubMed |
| A comprehensive molecular analysis of 113 primary ovarian clear cell carcinomas reveals common therapeutically significant aberrations. | Diagn Pathol | 2023 | 37303048 | PubTator, text mining | PubMed |
| Fusion sequencing via terminator-assisted synthesis (FTAS-seq) identifies TMPRSS2 fusion partners in prostate cancer. | Mol Oncol | 2023 | 37300660 | PubTator, text mining | PubMed |
| Therapeutic implications of cancer stem cells in prostate cancer. | Cancer Biol Med | 2023 | 37282627 | PubTator, text mining | PubMed |
| Characterisation of cell lines derived from prostate cancer patients with localised disease. | Prostate Cancer Prostatic Dis | 2023 | 37264224 | PubTator, text mining | PubMed |
| Cutaneous metastasis as the first presentation of poorly differentiated renal cell carcinoma: A case report. | Urol Case Rep | 2023 | 37250965 | PubTator, text mining | PubMed |
| Current Knowledge and Prospects for Renal Hemangioblastoma and Renal Cell Carcinoma with Hemangioblastoma-like Features. | Biomedicines | 2023 | 37239138 | PubTator, text mining | PubMed |
| Morphologic spectrum of the epithelial tumors of the male and female urethra. | Virchows Arch | 2023 | 37233807 | PubTator, text mining | PubMed |
| Coexistence of multiple clear cell papillary renal cell carcinoma with renal oncocytoma: a case report. | Ann Med Surg (Lond) | 2023 | 37228922 | PubTator, text mining | PubMed |
| Reviewing the Prospective Pharmacological Potential of Isothiocyanates in Fight against Female-Specific Cancers. | Cancers (Basel) | 2023 | 37190316 | PubTator, text mining | PubMed |
| Recent Progress in Development and Application of DNA, Protein, Peptide, Glycan, Antibody, and Aptamer Microarrays. | Biomolecules | 2023 | 37189350 | PubTator, text mining | PubMed |
| Spatial analysis with SPIAT and spaSim to characterize and simulate tissue microenvironments. | Nat Commun | 2023 | 37188662 | PubTator, text mining | PubMed |
| Correlations of PTEN and ERG Immunoexpression in Prostate Carcinoma and Lesions Related to Its Natural History: Clinical Perspectives. | Curr Issues Mol Biol | 2023 | 37185705 | PubTator, text mining | PubMed |
| Prostate Cancer Metastasis to Stomach: A Case Report and Review of Literature. | Curr Oncol | 2023 | 37185408 | PubTator, text mining | PubMed |
| Xp11.2 Translocation Renal Cell Carcinoma: A Rare Renal Cell Carcinoma. | Cureus | 2023 | 37153295 | PubTator, text mining | PubMed |
| Synchronous ipsilateral papillary renal cell carcinoma and urothelial carcinoma: A case report. | Oncol Lett | 2023 | 37153050 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23600/papers?page=12